# OnCo record paper-mailankody-jama-oncol (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-mailankody-jama-oncol/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-mailankody-jama-oncol" ;
  schema:name "Five Years of Cancer Drug Approvals: Innovation, Efficacy, and Costs"@en ;
  schema:description "Paper cited by one bottleneck page, indexed on Europe PMC as PubMed record 26181265 and published in JAMA Oncology; the citing page links this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-mailankody-jama-oncol/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1001/jamaoncol.2015.0373>, <https://pubmed.ncbi.nlm.nih.gov/26181265/>, <https://europepmc.org/article/MED/26181265> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1001/jamaoncol.2015.0373> ;
  schema:datePublished "2015"^^xsd:gYear ;
  schema:author "Mailankody S, Prasad V" ;
  onco:related <https://onco.cc/bottlenecks/b-incentive-misalignment/> ;
  onco:journals <https://onco.cc/journals/jama-oncology/> .
